Predictmedix AI Inc. (PMED.CN)
Chart Events
Performance Outlook
| Previous Close | 0.1000 |
| Open | 0.0950 |
| Bid | 0.0850 x N/A |
| Ask | 0.0950 x N/A |
| Day's Range | 0.0850 - 0.0950 |
| 52 Week Range | 0.0250 - 0.1600 |
| Volume | |
| Avg. Volume | 159,055 |
| Market Cap | 11.416M |
| Beta (5Y Monthly) | 1.57 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for PMED.CN
Related Research
ACCESSWIREPredictmedix AI Executives Departing This Weekend for Strategic Collaborations in India
Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix") today announced that visas have been granted for a strategic visit to India. The primary purpose of the company's executives' visit is to engage with institutional partners and government officials in India, with a keen focus on ensuring seamless integration and scalable deployment of Predictmedix's cutting-edge contactless AI solutions.
- ACCESSWIRE
Predictmedix AI Showcased in Toronto Star Newspaper; Accelerates Oxygen Saturation Parameter to Accommodate Widespread Respiratory Health Issues
Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix") is proud to announce its recent feature in the prestigious Toronto Star newspaper, accompanied by a compelling interview with the company's COO, Dr. Rahul Kushwah. This exciting development marks a significant milestone in Predictmedix's journey, enhancing the company's visibility and attracting both business opportunities and investor attention.
- ACCESSWIRE
Predictmedix AI's 2023 Breakthroughs: Pioneering Healthcare Innovation and Global Expansion
Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix") today provided an update on its achievements and developments so far in 2023.
